PharmaNet Opens Brazil Office

PharmaNet Development Group opened a new office in Sao Paulo, Brazil. The new office is part of the company’s efforts to provide services in this region, which is considered to be a desired location for clinical research due to its qualified investigators, large patient population, standard of care and regulatory standards, which are aligned with U.S. and EU regulations.

The company has provided clinical trial support in Latin America since 2002 and has staff in Brazil, Mexico and Peru and an office in Argentina. 

“The number of clinical trials in Latin America has experienced significant growth over the past 10 years,” said Fernanda Duran, executive director, Latin American operations. “Our clients are more actively requesting Latin American sites in order to meet aggressive timelines for patient recruitment, thus bringing their new drugs to market sooner. I am thrilled about opening this office in Brazil which will enhance our infrastructure in the region.”

“We are excited to continue our expansion into Latin America, a region which offers excellent resources for conducting clinical trials,” said Jeffrey P. McMullen, president and chief executive officer. “In addition to our Buenos Aires office, we have superior field-based staff in the area and the new office will provide them with the facilities to continue to demonstrate their high-quality work for our clients.”